VCANBIO CELL & GENE ENGINEERING CORP., LTD

Other languages Vcanbio Cell & Gene Engineering Corp., Ltd

Equities

600645

CNE000000545

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
18.56 ^CNY	+0.71%		-8.03%	-8.44%

Apr. 25	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 25	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25
Vcanbio Cell & Gene Engineering Corp., Ltd announces an Equity Buyback for CLP 200 million worth of its shares.	Feb. 18
Vcanbio Cell & Gene Engineering Corp., Ltd authorizes a Buyback Plan	Feb. 16
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27
Vcanbio Cell & Gene Gets Greenlight to Trial COVID-19 Drug	23-10-16
MET Group signs energy supply deal with Commonwealth LNG	23-09-04
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24
Vcanbio Cell & Gene’s Pulmonary Fibrosis Treatment Wins Orphan Drug Designation in US	23-08-14
Vcanbio Cell & Gene Unit Gets Nod to Begin Clinical Trial of Respiratory Distress Medication	23-06-08
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25
Vcanbio Cell & Gene Engineering Wins Nod to Trial Stem Cell Therapy For Liver Cirrhosis	23-02-13
C-Mer Eye Care Raises HK$116.1 Million in Share Subscription Deal	22-12-08
C-Mer Eye Care To Issue More Than 30 Million New Shares to Vcanbio Cell Chairman	22-12-04
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29
Energy firms MET and HH2E to invest in Baltic electrolysis plant	22-06-15
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-24
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Vcanbio Cell & Gene Engineering Corp., Ltd

Equities

600645

CNE000000545

Other languages

Filters